Hikari Tsushin Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.8M | Hold |
104,963
| – | – | 1.57% | 9 |
|
|
2025
Q4 | $24M | Hold |
104,963
| – | – | 1.56% | 9 |
|
|
2025
Q3 | $24.3M | Hold |
104,963
| – | – | 1.63% | 9 |
|
|
2025
Q2 | $19.5M | Hold |
104,963
| – | – | 1.37% | 10 |
|
|
2025
Q1 | $22M | Hold |
104,963
| – | – | 1.47% | 10 |
|
|
2024
Q4 | $18.7M | Hold |
104,963
| – | – | 1.35% | 10 |
|
|
2024
Q3 | $20.7M | Hold |
104,963
| – | – | 1.47% | 10 |
|
|
2024
Q2 | $18M | Hold |
104,963
| – | – | 1.39% | 10 |
|
|
2024
Q1 | $19.1M | Hold |
104,963
| – | – | 1.52% | 9 |
|
|
2023
Q4 | $16.3M | Hold |
104,963
| – | – | 1.49% | 9 |
|
|
2023
Q3 | $15.6M | Sell |
104,963
-5,114
| -5% | -$751K | 1.52% | 9 |
|
|
2023
Q2 | $14.8M | Hold |
110,077
| – | – | 1.42% | 9 |
|
|
2023
Q1 | $17.5M | Hold |
110,077
| – | – | 1.83% | 7 |
|
|
2022
Q4 | $17.8M | Hold |
110,077
| – | – | 1.89% | 8 |
|
|
2022
Q3 | $14.8M | Hold |
110,077
| – | – | 1.8% | 9 |
|
|
2022
Q2 | $16.9M | Hold |
110,077
| – | – | 2.22% | 7 |
|
|
2022
Q1 | $17.8M | Hold |
110,077
| – | – | 1.79% | 9 |
|
|
2021
Q4 | $14.9M | Buy |
+110,077
| New | +$13M | 1.63% | 11 |
|
|
2021
Q2 | $12.6M | Buy |
112,119
+63,599
| +131% | +$7.16M | 1.55% | 12 |
|
|
2021
Q1 | $5.25M | Buy |
48,520
+39,240
| +423% | +$4.2M | 0.71% | 20 |
|
|
2020
Q4 | $994K | Buy |
+9,280
| New | +$892K | 0.15% | 32 |
|
|
2016
Q4 | – | Sell |
-59,550
| Closed | -$3.76M | – | 28 |
|
|
2016
Q3 | $3.76M | Hold |
59,550
| – | – | 0.99% | 17 |
|
|
2016
Q2 | $3.69M | Hold |
59,550
| – | – | 0.91% | 18 |
|
|
2016
Q1 | $3.4M | Hold |
59,550
| – | – | 0.8% | 21 |
|
|
2015
Q4 | $3.53M | Hold |
59,550
| – | – | 0.91% | 17 |
|
|
2015
Q3 | $3.24M | Sell |
59,550
-6,617
| -10% | -$431K | 0.86% | 17 |
|
|
2015
Q2 | $4.45M | Sell |
66,167
-3,260
| -5% | -$213K | 0.97% | 18 |
|
|
2015
Q1 | $4.06M | Sell |
69,427
-30,073
| -30% | -$1.82M | 0.81% | 20 |
|
|
2014
Q4 | $6.51M | Sell |
99,500
-6,500
| -6% | -$410K | 1.2% | 20 |
|
|
2014
Q3 | $6.12M | Sell |
106,000
-21,100
| -17% | -$1.17M | 1.14% | 22 |
|
|
2014
Q2 | $7.17M | Hold |
127,100
| – | – | 1.13% | 24 |
|
|
2014
Q1 | $6.53M | Hold |
127,100
| – | – | 1.1% | 23 |
|
|
2013
Q4 | $6.71M | Hold |
127,100
| – | – | 1.14% | 22 |
|
|
2013
Q3 | $5.68M | Hold |
127,100
| – | – | 1.08% | 19 |
|
|
2013
Q2 | $5.25M | Buy |
+127,100
| New | +$5.56M | 1.2% | 20 |
|
Other funds holding ABBV
VCM
VPM
Hikari Tsushin Inc's ABBV Position: Q1 2026 in Review
Hikari Tsushin Inc held its AbbVie (ABBV) position steady in Q1 2026 at 104,963 shares worth $22.8M. The position accounts for 1.57% of the portfolio, ranked #9.
Hikari Tsushin Inc first reported a position in ABBV in Q2 2013 and has held it in 35 quarters since. The position peaked at $24.3M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Hikari Tsushin Inc held 104,963 shares of AbbVie worth $22.8M as of Q1 2026.
- Hikari Tsushin Inc left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 1.57% of Hikari Tsushin Inc's portfolio in Q1 2026, its #9 holding.
- Hikari Tsushin Inc first reported a position in AbbVie in Q2 2013 and has held it in 35 quarters since.
- Hikari Tsushin Inc's AbbVie position peaked at $24.3M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Hikari Tsushin Inc's 13F filing for Q1 2026, filed 13 May 2026.